BioMarin Pharmaceutical Inc (BMRN)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$61.00

Buy

$61.35

arrow-up$9.20 (+17.71%)

Prices updated at 20 Dec 2025, 00:59 EST

Prices minimum 15 mins delay

Prices in USD

Biomarin Pharmaceutical Inc is on rare-disease therapies. It develops and commercializes pharmaceuticals for serious diseases and medical conditions.

NASDAQ

1.31%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$63.89 - $54.39
	$73.51 - $50.76
	-
	11,747.79m
	22.73
	-
	18,520,186
	1.94
	2,174,678.49
	0.42
	190.76m
	US09061G1013
	2.69
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.